読み込み中
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
前日終値
$27.28
+$0.89 · +3.37%
日中の時刻はETです。市場データは遅延する場合があります。
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
日中レンジ
現在 $27.28
52週レンジ
現在 $27.28
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
中立
バリュエーション
47
適正価値
センチメント
51
まちまち
リスク
61
高リスク
モメンタム
54
中立
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
日中レンジ
現在 $27.28
52週レンジ
現在 $27.28
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標（USD） | 2025年度 | 2024年度 | 2023年度 | 2022年度 | 2021年度 |
|---|---|---|---|---|---|
| 売上高 | 2.56億 USD | 2.08億 USD | 2.17億 USD | 1.81億 USD | 1.38億 USD |
| 売上原価 | 1.13億 USD | 7545.6万 USD | 7597.4万 USD | 7993.3万 USD | 7231.1万 USD |
| 粗利益 | 1.43億 USD | 1.32億 USD | 1.41億 USD | 1.01億 USD | 6562万 USD |
| 研究開発 | 1.73億 USD | 2.02億 USD | 1.82億 USD | 1.26億 USD | 9090.4万 USD |
| 販売・一般管理 | 1.36億 USD | 1.4億 USD | 1.36億 USD | 1.21億 USD | 8615.9万 USD |
| 営業費用 | 3.1億 USD | 3.41億 USD | 3.18億 USD | 2.48億 USD | 1.77億 USD |
| 受取利息 | — | — | — | 395万 USD | 105.7万 USD |
| 支払利息 | — | — | — | 3000 USD | — |
| 減価償却費と償却費 | 602.2万 USD | 615.9万 USD | 555.2万 USD | 434.4万 USD | 284.7万 USD |
| 営業利益 | −1.67億 USD | −2.09億 USD | −1.77億 USD | −1.47億 USD | −1.11億 USD |
| 純利益 | −1.03億 USD | −1.87億 USD | 4072万 USD | −1.49億 USD | −1億 USD |
会社概要が更新されました 2026年10月11日.
直近の発表実績
直近の発表実績
第三者のアナリスト予想は変更される場合があり、GoAIの推奨ではありません。
平均目標
$19.00
下落余地（30.35%）この株式へのエクスポージャーを報告している上場投資信託です。
ARK Genomic Revolution ETFARKG5925.86万2.89%15.57億 USD0.75%$51.30+4.08%
iShares Russell 2000 ETFIWM4041.25万0.05%787.4億 USD0.19%$278.94+0.49%
Vanguard Morningstar Total Stock Market ETFVTI3831.88万0.00%2.3兆 USD0.03%$381.94+0.63%
Vanguard Morningstar Small-Cap ETFVB2785.67万0.01%1853億 USD0.03%$289.48+0.64%
Vanguard Morningstar Small-Cap Growth ETFVBK1600.65万0.04%447億 USD0.05%$344.74+1.22%
iShares Russell 2000 Growth ETFIWO1410.03万0.10%139.17億 USD0.24%$356.78+0.94%
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM1389.78万0.09%158.4億 USD0.03%$53.45+0.17%
Vanguard Extended Market ETFVXF1295.4万0.01%954億 USD0.05%$235+0.80%ARK Genomic Revolution ETFARKGiShares Russell 2000 ETFIWMVanguard Morningstar Total Stock Market ETFVTIVanguard Morningstar Small-Cap ETFVBVanguard Morningstar Small-Cap Growth ETFVBKiShares Russell 2000 Growth ETFIWOState Street SPDR Portfolio S&P 600 Small Cap ETFSPSMVanguard Extended Market ETFVXFAIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。
